The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(4-Fluorobenzyl)-2-(methylthio)-4-pyrrolidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine ID: ALA4088440
PubChem CID: 137642749
Max Phase: Preclinical
Molecular Formula: C18H19FN4S
Molecular Weight: 342.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CSc1nc(N2CCCC2)c2ccn(Cc3ccc(F)cc3)c2n1
Standard InChI: InChI=1S/C18H19FN4S/c1-24-18-20-16(22-9-2-3-10-22)15-8-11-23(17(15)21-18)12-13-4-6-14(19)7-5-13/h4-8,11H,2-3,9-10,12H2,1H3
Standard InChI Key: BBTSLIHTQGHZBD-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
8.9506 -17.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6699 -18.0545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3759 -17.6307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3626 -16.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6433 -16.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9332 -16.8289 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1668 -17.8700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1454 -16.5372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6407 -17.1937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6301 -15.5803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2866 -15.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0179 -14.3023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1932 -14.3155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9538 -15.1064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2404 -18.0775 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.5213 -17.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4355 -18.6526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2460 -18.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5147 -19.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3212 -19.7483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8630 -19.1262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5944 -18.3434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7879 -18.1870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6736 -19.2826 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
8 9 2 0
7 9 1 0
3 7 1 0
4 8 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
10 14 1 0
5 10 1 0
15 16 1 0
1 15 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
21 24 1 0
7 17 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.44Molecular Weight (Monoisotopic): 342.1314AlogP: 3.94#Rotatable Bonds: 4Polar Surface Area: 33.95Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.20CX LogP: 5.02CX LogD: 5.00Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.53Np Likeness Score: -1.90
References 1. Musumeci F, Fallacara AL, Brullo C, Grossi G, Botta L, Calandro P, Chiariello M, Kissova M, Crespan E, Maga G, Schenone S.. (2017) Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma., 127 [PMID:28076826 ] [10.1016/j.ejmech.2016.12.036 ]